Two Sigma Securities, LLC Alnylam Pharmaceuticals, Inc. Call Options Transaction History

Two Sigma Securities, LLC

$5.78 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$233.81 - $287.01 $1.47 Million - $1.81 Million	-6,300 Reduced 63.0%	3,700 $1.02 Million
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $28,662 - $49,400	-200 Reduced 1.96%	10,000 $2.43 Million
Q1 2024 May 15, 2024	SELL	$146.51 - $198.2 $43,953 - $59,460	-300 Reduced 2.86%	10,200 $1.52 Million
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $1.29 Million - $1.67 Million	8,500 Added 425.0%	10,500 $2.01 Million
Q3 2023 Nov 14, 2023	BUY	$170.77 - $211.65 $68,308 - $84,660	400 Added 25.0%	2,000 $354,000
Q2 2023 Aug 14, 2023	BUY	$185.01 - $212.05 $296,016 - $339,280	1,600 New	1,600 $303,000
Q4 2022 Feb 14, 2023	SELL	$185.53 - $241.31 $92,765 - $120,655	-500 Reduced 35.71%	900 $213,000
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $193,956 - $324,800	1,400 New	1,400 $280,000
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $534,156 - $730,422	4,200 New	4,200 $686,000
Q1 2021 May 17, 2021	SELL	$126.83 - $175.69 $266,343 - $368,949	-2,100 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$121.19 - $165.49 $363,570 - $496,470	-3,000 Reduced 58.82%	2,100 $306,000
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $380,001 - $633,573	5,100 New	5,100 $587,000
Q2 2019 Aug 14, 2019	SELL	$65.86 - $92.79 $256,854 - $361,881	-3,900 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$72.76 - $93.45 $283,764 - $364,455	3,900 New	3,900 $364,000
Q4 2018 Feb 14, 2019	SELL	$62.67 - $88.33 $564,030 - $794,970	-9,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$87.52 - $122.67 $175,040 - $245,340	2,000 Added 28.57%	9,000 $788,000
Q2 2018 Aug 14, 2018	SELL	$88.31 - $107.8 $1.05 Million - $1.28 Million	-11,900 Reduced 62.96%	7,000 $689,000
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $1.34 Million - $1.72 Million	11,600 Added 158.9%	18,900 $2.25 Million
Q4 2017 Feb 14, 2018	BUY	$114.49 - $139.98 $835,777 - $1.02 Million	7,300	7,300 $927,000

Others Institutions Holding ALNY

# of Institutions

643

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$4.05 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$3.1 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.34 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.29 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.22 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account